123 related articles for article (PubMed ID: 1832327)
1. Infra-additivity of combined treatments with selective D1 and D2 receptor antagonists for inhibiting sucrose reinforcement.
Schneider LH; Watson CA; Gibbs J; Smith GP
Brain Res; 1991 May; 550(1):122-4. PubMed ID: 1832327
[TBL] [Abstract][Full Text] [Related]
2. The potency of D-1 and D-2 receptor antagonists is inversely related to the reward value of sham-fed corn oil and sucrose in rats.
Weatherford SC; Greenberg D; Gibbs J; Smith GP
Pharmacol Biochem Behav; 1990 Oct; 37(2):317-23. PubMed ID: 2150443
[TBL] [Abstract][Full Text] [Related]
3. D-1 and D-2 receptor antagonists decrease corn oil sham feeding in rats.
Weatherford SC; Smith GP; Melville LD
Physiol Behav; 1988; 44(4-5):569-72. PubMed ID: 2907161
[TBL] [Abstract][Full Text] [Related]
4. Subtypes of dopamine receptors involved in the mechanism of reinforcement.
Nakajima S
Neurosci Biobehav Rev; 1989; 13(2-3):123-8. PubMed ID: 2530477
[TBL] [Abstract][Full Text] [Related]
5. Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behaviour.
Nakajima S; Baker JD
Psychopharmacology (Berl); 1989; 98(3):330-3. PubMed ID: 2501812
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopamine D1 and dopamine D2 antagonists on the free feeding and drinking patterns of rats.
Clifton PG; Rusk IN; Cooper SJ
Behav Neurosci; 1991 Apr; 105(2):272-81. PubMed ID: 1675060
[TBL] [Abstract][Full Text] [Related]
7. A role for D2, but not D1, dopamine receptors in the response-reinstating effects of food reinforcement.
Chausmer AL; Ettenberg A
Pharmacol Biochem Behav; 1997 Aug; 57(4):681-5. PubMed ID: 9258994
[TBL] [Abstract][Full Text] [Related]
8. Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats.
Levin ED
Behav Neural Biol; 1988 Sep; 50(2):240-5. PubMed ID: 2906537
[TBL] [Abstract][Full Text] [Related]
9. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
Swerdlow NR; Keith VA; Braff DL; Geyer MA
J Pharmacol Exp Ther; 1991 Feb; 256(2):530-6. PubMed ID: 1825226
[TBL] [Abstract][Full Text] [Related]
10. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of acute dopaminergic D1 and D2 receptor antagonists on proneurotensin mRNA expression in rat striatum.
Augood SJ; Kiyama H; Faull RL; Emson PC
Brain Res Mol Brain Res; 1991 Mar; 9(4):341-6. PubMed ID: 1645436
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
Iorio LC; Cohen M; Coffin VL
J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
[TBL] [Abstract][Full Text] [Related]
13. Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for sucrose.
D'Aquila PS
Neuropharmacology; 2010 Jun; 58(7):1085-96. PubMed ID: 20149807
[TBL] [Abstract][Full Text] [Related]
14. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].
Ogren SO; Fuxe K
Neurosci Lett; 1988 Mar; 85(3):333-8. PubMed ID: 2966309
[TBL] [Abstract][Full Text] [Related]
15. Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes.
Agmo A; Federman I; Navarro V; Padua M; Velazquez G
Pharmacol Biochem Behav; 1993 Sep; 46(1):183-94. PubMed ID: 8255911
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic D1 and D2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum.
Augood SJ; Kiyama H; Faull RL; Emson PC
Neuroscience; 1991; 44(1):35-44. PubMed ID: 1685231
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory potency of SCH 23390 and raclopride on licking for sucrose increases across brief-access tests.
Smith GP; Smith JC
Physiol Behav; 2010 Oct; 101(3):315-9. PubMed ID: 20515702
[TBL] [Abstract][Full Text] [Related]
18. D1/D2 dopamine receptor stimulation by L-dopa. A [14C]-2-deoxyglucose autoradiographic study.
Trugman JM; James CL; Wooten GF
Brain; 1991 Jun; 114 ( Pt 3)():1429-40. PubMed ID: 1829645
[TBL] [Abstract][Full Text] [Related]
19. Microcatalepsy and disruption of forelimb usage during operant behavior: differences between dopamine D1 (SCH-23390) and D2 (raclopride) antagonists.
Fowler SC; Liou JR
Psychopharmacology (Berl); 1994 Jun; 115(1-2):24-30. PubMed ID: 7862901
[TBL] [Abstract][Full Text] [Related]
20. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
Wardas J; Pietraszek M; Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
